ArticleClinical epigenetics2020

Chidamide, decitabine, cytarabine, aclarubicin, and granulocyte colony-stimulating factor (CDCAG) in patients with relapsed/refractory acute myeloid leukemia: a single-arm, phase 1/2 study.

Lixin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.